STAAR Surgical Company (STAA)
Liquidity ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 5.62 | 6.11 | 6.05 | 6.65 | 6.03 | 6.55 | 6.37 | 6.65 | 5.56 | 5.64 | 5.94 | 6.19 | 5.25 | 5.79 | 5.78 | 5.75 | 5.07 | 5.50 | 5.53 | 5.41 |
| Quick ratio | 4.89 | 5.33 | 5.36 | 5.78 | 5.35 | 5.92 | 4.35 | 4.69 | 5.03 | 4.19 | 4.14 | 4.49 | 4.60 | 3.79 | 3.68 | 3.71 | 3.48 | 3.75 | 3.60 | 3.62 |
| Cash ratio | 3.39 | 3.31 | 3.54 | 4.33 | 4.09 | 4.66 | 4.35 | 4.69 | 4.09 | 4.19 | 4.14 | 4.49 | 3.70 | 3.79 | 3.68 | 3.71 | 3.48 | 3.75 | 3.60 | 3.62 |
STAAR Surgical Company has exhibited strong liquidity ratios over the past few quarters. The current ratio has consistently remained above 5, indicating a healthy ability to meet short-term obligations with current assets. The quick ratio, which excludes inventory from current assets, has also been robust, signaling that the company can cover immediate liabilities without relying on selling inventory. Furthermore, the cash ratio has been relatively stable, indicating the company's ability to meet current liabilities using only its most liquid assets.
Overall, the consistent high values of the current ratio, quick ratio, and cash ratio suggest that STAAR Surgical Company has a strong liquidity position and is well-equipped to handle any short-term financial challenges or obligations that may arise.
Additional liquidity measure
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash conversion cycle | days | 406.66 | 419.10 | 331.38 | 353.75 | 303.41 | 268.45 | -79.71 | -90.45 | 254.51 | -67.01 | -56.83 | -61.78 | 315.93 | -65.76 | -78.66 | -86.20 | -76.86 | -75.63 | -86.23 | -77.19 |
The cash conversion cycle of STAAR Surgical Company has shown fluctuations over the analyzed periods.
- The company's cycle ranged from negative days (indicating rapid conversion of inventory to cash) to positive days (indicating a longer time to convert inventory into cash) throughout the different quarters.
- During some periods, such as in June 2022, March 2022, September 2020, and June 2020, the cash conversion cycle was remarkably negative, reflecting efficient management of working capital and quick conversion of inventory to cash.
- However, there were also times when the cash conversion cycle was significantly positive, such as in September 2023 and December 2023, indicating a longer time to convert inventory into cash, potentially pointing to challenges in managing working capital efficiently.
- Overall, understanding the drivers behind these fluctuations in the cash conversion cycle is essential for the company to optimize its working capital management and improve cash flow efficiency.